Latest stories on TRAW
H.C. Wainwright reiterates Neutral on Traws Pharma stock at $1
Investing.com Analyst Ratings50 · neutralanalyst
Traws Pharma shares rise after Q2 loss comes in better than expected
Yahoo Top58 · neutralearnings
Traws Pharma shares rise after Q2 loss comes in better than expected
InvestorsHub56 · neutralearnings
Traws Pharma GAAP EPS of -$0.16 beats by $0.06
Seeking Alpha56 · neutralearnings
Traws Pharma, Inc. (TRAW) files 8-K
SEC 8-K50 · neutralgeneral
Traws Pharma Reports Q2 2026 Financial Results and Provides Business Highlights
StockTitan56 · neutralearnings
Traws Pharma Reports Q2 2026 Financial Results and Provides Business Highlights
GlobeNewswire56 · neutralearnings
Traws Pharma, Inc. (TRAW) files 8-K
SEC 8-K34 · bearishgeneral
Traws Pharma, Inc. (TRAW) files 8-K
SEC 8-K50 · neutralgeneral
Traws Pharma, Inc. (TRAW) files 8-K
SEC 8-K50 · neutralgeneral
Traws Pharma prepares new toxicology package for influenza drug
TipRanks58 · neutralproduct/pr
Traws Pharma, Inc. (TRAW) files 8-K
SEC 8-K50 · neutralgeneral
Traws Pharma Provides Updated Guidance on Influenza Prophylaxis Program | TRAW Stock News
StockTitan58 · neutralproduct/pr
Why Did TRAW Stock Slump 28% After Hours?
Stocktwits News28 · bearishgeneral
Traws Pharma Defers Phase 2a Influenza Study Plans
TipRanks34 · bearishproduct/pr
Traws Pharma Provides Regulatory Update on Influenza Program | TRAW Stock News
StockTitan34 · bearishproduct/pr
Traws Pharma, Inc. (TRAW) files 8-K
SEC 8-K50 · neutralgeneral
Traws Pharma Advances Broad-Spectrum Antiviral for Emerging Outbreaks
TipRanks63 · neutralproduct/pr
Traws Pharma Announces Antiviral Program Targeting Ongoing Hantavirus and Ebola Virus Disease Outbreaks | TRAW Stock News
StockTitan63 · neutralproduct/pr
Traws Pharma Updates ATM Equity Offering Prospectus Supplements
TipRanks28 · bearishgeneral
Traws Pharma GAAP EPS of -$0.53 beats by $0.03, revenue of $0M
Seeking Alpha56 · neutralearnings